Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing
Reexamination Certificate
2002-05-13
2004-11-09
Afremova, Vera (Department: 1651)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
C424S195170, C435S257100, C435S946000
Reexamination Certificate
active
06814961
ABSTRACT:
FIELD
This invention relates to methods of enhancing animal stem cell trafficking, specifically to the use of blue green algae, or a biological component thereof, to enhance the trafficking or homing of such stem cells.
BACKGROUND
Stem cells are pluripotent cells derived from somatic tissue capable of differentiating into more specialized cells. For example, hematopoietic stem cells can differentiate into many different types of blood cells, including red blood cells, platelets, and leukocytes.
Hematopoietic stem cells are quite abundant and play a role in the continuous lifelong physiological replenishment of blood cells. Stem cells develop into both hematopoietic lineage cells and non-hematopoietic, tissue specific cells. Recently, stem cells have been found to differentiate into a variety of tissue-specific cell types, such as myocytes, hepatocytes, osteocytes, glial cells, and neurons. For example, stem cells have been shown to cross the blood-brain barrier (Willams and Hickey,
Curr. Top. Microbiol. Immunol
202:221-245, 1995) and differentiate into neurons (Mezey, Science 290:1779-82, 2000). Thus, it is possible that stem cells could be used to treat Parkinson's disease (Polli,
Haematologica
85:1009-10,2000), Alzheimer's disease (Mattson,
Exp. Gerontol.
35:489-502, 2000), and traumatic brain injury (Magavi,
Nature
405: 892-3, 895, 2000). Stem cells also have been shown to differentiate into fibroblast or fibroblast-like cells, and to express collagen (Periera et al.,
Proc. Natl. Acad. Sci.
95:1142-7, 1998). Thus, it is possible that stem cells can be used to treat osteogenesis imperfecta and bone fractures. Peterson et al. (
Science
284:1168-70, 1999) also have shown that liver cells can arise from stem cells. Thus, stem cells may be of use in treating a variety of pathologies of the liver, including, but not limited to cirrhosis. In addition, bone marrow derived stem cells have been demonstrated to migrate to the site of a myocardial infarction and form myocardium (Orlic,
Nature
410:701-5, 2000). Thus, stem cells may be use in treating myocardial infarction.
Since stem cells are capable of differentiating into a broad variety of cell types, they play an important role in the healing and regenerative processes of various tissues it and organs. See Koc, O. N., and Lazarus, H. M.,
Bone Marrow Transplant,
27(3):235-39 (2001). Bone marrow stem cells, including marrow stromal cells (MSCs), injected into a recipient's circulatory system can integrate into various organs and tissues to become mature, terminally differentiated cells. Therefore, activation and enhancement of stem cell trafficking can amplify these physiological processes and provide a potential therapy for various pathologies.
SUMMARY
A method is disclosed herein for enhancing trafficking of stem cells by administering a therapeutically effective amount of blue green algae to a subject. In one embodiment, whole cells of a blue-green algae, or extracts thereof, are administered to the subject to enhance stem cell trafficking. The algae cells may be fresh, dehydrated, or preserved in some manner. In another embodiment, a high-molecular weight polysaccharide fraction of the blue green algae is administered to the subject. Pharmaceutical compositions including a therapeutically effective amount of a blue green algae, or a component thereof, are disclosed herein.
In one embodiment, a therapeutically effective amount of blue-green algae induces a transient increase in the population of some stem cells, such as CD34+ stem cells, in the subject's circulatory system. The percentage increase in the number of circulating stem cells, compared to a control, is more than about 10%, more than about 25%, more than about 50%, more than about 100%, more than about 200%, more than about 400%, or more than about 500% following administration of the blue green algae. Additionally, administration of certain fractions of whole AFA can increase the homing of stem cells to various parts of the body, evidenced by a decrease in the number of circulating stem cells. For example, administration of a polysaccharide rich fraction of whole AFA increases the homing of CD34+ and NK cells from the circulatory system to various parts of the body.
In some embodiments, the subject provided the blue-green algae is healthy. In other embodiments, the subject suffers a disease or physiological condition.
REFERENCES:
patent: 5585365 (1996-12-01), Hayashi et al.
patent: 6261549 (2001-07-01), Fernandez et al.
patent: 2000253853 (2000-09-01), None
Kushak et al. Book of Abstracts, 217th ACS National Meeting, Calif., Mar. 21025 (1999), AGFD-045.*
Azizi S.A., et al., “Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats-similarities to astrocyte grafts,”Proc Natl Acad Sci USA, 95(7):3908-13, 1998.
Brazelton, T.R., et al., “From marrow to brain: expression of neuronal phenotypes in adult mice,”Science, 290(5497):1775-9, 2000.
Eglitis, J., et al., “Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice,”Proc. Natl Acad Sci USA, 94(8):4080-5, 1997.
Fallon, J., et al., “In vivo induction of massive proliferation, directed migration, and differentiation of neural cells in the adult mammalian brain,”Proc Natl Acad Sci USA, 97(26):14686-91, 2000.
Ferrari, G., et al., “Muscle regeneration by bone marrow-derived myogenic progenitors,”Science, 279(5356):1528-30, 1998.
Frenette, P.S., and Weiss, L., “Sulfated glycans induce rapid hematopoietic progenitor cell mobilization: evidence for selectin-dependent and independent mechanisms,”Blood, 96(7):2460-2468, 2000.
Hickey, W.F., “Leukocyte traffic in the central nervous system: the participants and their roles,”Semin Immunol, 11(2):125-37, 1999.
Hidalgo, A., et al.,Exp. Hematol.,29(3):345-55, 2001.
Knopf P.M., et al, “Antigen-Dependent Intrathecal Antibody Synthesis in Normal Rat Brain: Tissue Entry and Local Retention of Antigen-Specific B Cells.”J. Immunol.,161, p. 692, 1998.
Koc, O.N. and Lazarus, H.M., “Mesenchymal stem cells: heading into the clinic,”Bone Marrow Transplant, 27(3):235-9, 2001.
Kocher, A.A., et al., “Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function,”Nat Med,7:430-36, 2001.
Kollet, O., et al.,Blood, 97(10):3283-91, 2001.
Kopen, G.C., et al., “Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains,”Proc Natl Acad Sci USA, 96(19):10711-6, 1999.
Kozenko, R., and Henson, R.H., “The Study of Spirulina—Effects on the AIDS Virus, Cancer and the Immune System,”Health&Natural Journal.
Lagasse, E., et al., “Purified hematopoietic stem cells can differentiate into hepatocytes in vivo,”Nat Med, 6(11):1299-35, 2000.
Lasley, E.N., “Death Leads to Brain Neuron Birth,”Science, 288(5474):2111-12, 2000.
Magavi S.S., et al., “Induction of neurogenesis in the neocortex of adult mice,”Nature, 405(6789):892-3, 895, 2000.
Mattson, M.P., “Emerging neuroprotective strategies for Alzheimer's disease: dietary restriction, telomerase activation, and stem cell therapy,”Exp Gerontol, 35(4):489-502, 2000.
Mattson, M.P., “Existing data suggest that Alzheimer's disease is preventable,”Ann N Y Acad Sci, 924:153-9, 2000.
Mezey, E., et al., “Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow,”Science, 290(5497):1779:82, 2000.
Orlic D., et al., “Bone marrow cells regenerate infarcted mycardium,”Nature, 410(6829):701-5, 2001.
Pereira, R.F., et al., “Marrow stromal cells as source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta,”Proc Natl Acad Sci USA, 95(3):1142-7, 1998.
Polli, E.E., “Transplanting bone-marrow stem cells in the central nervous system,”Haematologica, 85(10):1009-10, 2000.
Petersen, B.E., et al., “Bone marrow as a potential source of hepatic oval cells ,”Science, 284(5417):1168-
Drapeau Christian
Jensen Gitte S.
Afremova Vera
Klarquist & Sparkman, LLP
LandOfFree
Method for enhancing stem cell trafficking does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for enhancing stem cell trafficking, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for enhancing stem cell trafficking will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3280935